Insider Trading March 16, 2026 09:07 PM

Sprouts Development Chief Disposes of $19,051 in Shares, While Firm Sees Mixed Analyst Reaction

Sale of 240 shares follows a restricted stock unit grant; company posts modest comp-store growth and EPS beat for Q4 FY2025

By Hana Yamamoto SFM

David McGlinchey, Chief Development Officer at Sprouts Farmers Market, sold 240 shares on March 13, 2026, generating proceeds of $19,051. A Form 4 filed with the SEC also records that McGlinchey received 4,421 shares the prior day through a restricted stock unit grant. The stock is trading above the sale price, while the company has recently reported mild comparable-store sales growth and an earnings beat that prompted mixed analyst responses.

Sprouts Development Chief Disposes of $19,051 in Shares, While Firm Sees Mixed Analyst Reaction
SFM

Key Points

  • Insider transaction: Chief Development Officer David McGlinchey sold 240 shares on March 13, 2026, netting $19,051 and received 4,421 RSU shares on March 12, 2026 at $0 per share.
  • Recent results: Sprouts posted a 1.6% increase in comparable store sales for Q4 FY2025 and delivered EPS of $0.92, both above certain analyst estimates.
  • Analyst responses: Price targets were lowered across several firms with mixed ratings; actions ranged from removal from a Tactical Underperform List to maintained Buy and Neutral stances.

David McGlinchey, Sprouts Farmers Market, Inc.'s Chief Development Officer, completed a sale of 240 shares of common stock on March 13, 2026, at $79.38 per share, for total proceeds of $19,051, according to regulatory filings. The transaction was reported on a Form 4 submitted to the Securities and Exchange Commission.

The sale comes shortly after McGlinchey was recorded as receiving 4,421 shares of Sprouts common stock on March 12, 2026, under a restricted stock unit grant. That acquisition was recorded at a per-share price of $0 on the Form 4.

At the time of the report, Sprouts stock was trading at $81.73 and the company carried a market capitalization of $7.74 billion. An InvestingPro note included with the coverage highlights that the shares have fallen materially over the last six months, down 33.75% over that period.

On the operational front, Sprouts reported a 1.6% increase in comparable store sales for the fourth quarter of fiscal 2025, outpacing Evercore ISI's projection of 0.8%. The company also posted earnings per share of $0.92 for the quarter, above Evercore ISI's $0.88 estimate and the consensus estimate of $0.89.

Following those results, Evercore ISI removed Sprouts from its Tactical Underperform List. Analyst reactions to the quarter and the stock have been mixed, however. UBS trimmed its price target to $75 from $108 while keeping a Neutral rating and cited growth concerns. BMO Capital lowered its target to $70 from $90, pointing to affordability issues. Evercore ISI cut its price target to $83 from $130 but maintained an Outperform rating while noting consumer concerns. Jefferies slightly reduced its target to $105 from $110 and kept a Buy rating, referencing increasing competitive pressures.

InvestingPro also provides a Pro Research Report that covers Sprouts and more than 1,400 other U.S. equities for users seeking additional context on valuation and financial metrics.

These developments present a combination of modest operational upside in the latest quarter and continuing analyst caution regarding growth, affordability and competitive dynamics.


Contextual note: The Form 4 filing documents an insider sale and an RSU grant in consecutive days; the reported analyst actions reflect varied views on Sprouts' near-term outlook and valuation.

Risks

  • Share performance: The stock has declined 33.75% over six months, indicating market pressure on the equity - impacts equity investors and retail sector sentiment.
  • Analyst concerns: Lowered price targets and notes on affordability and consumer concerns signal potential headwinds for revenue growth - affects grocery/consumer staples sector forecasts.
  • Competitive pressures: Analysts cited increasing competition, which could weigh on margins and growth prospects - relevant to investors assessing retail margin resilience.

More from Insider Trading

Twist Bioscience Executive Executes Automated Sell-to-Cover Stock Transaction May 6, 2026 Twist Bioscience CEO Executes Sell-to-Cover Transaction Amid Mixed Fiscal Results May 6, 2026 Twist Bioscience Executive Executes Tax-Related Stock Sale Amid Mixed Fiscal Results May 6, 2026 TechnipFMC Director Kay G Priestly Executes Stock Sale Amidst Recent Earnings Volatility May 6, 2026 Control Empresarial Reduces PBF Energy Stake via $19 Million Share Sale May 6, 2026